ABL Bio Inc. (298380.KQ)

KRW 64900.0

(0.31%)

Inventory Summary of ABL Bio Inc.

ABL Bio Inc.'s latest annual inventory in 2023 was - KRW , down 0.0% from previous year.
ABL Bio Inc.'s latest quarterly inventory in 2024 Q2 was - KRW , down -100.0% from previous quarter.
ABL Bio Inc. reported annual inventory of - KRW in 2022, down 0.0% from previous year.
ABL Bio Inc. reported annual inventory of - KRW in 2021, down 0.0% from previous year.
ABL Bio Inc. reported quarterly inventory of - KRW for 2024 Q2, down -100.0% from previous quarter.
ABL Bio Inc. reported quarterly inventory of - KRW for 2023 Q1, down 0.0% from previous quarter.

Annual Inventory Chart of ABL Bio Inc. (2023 - 2016)

Historical Annual Inventory of ABL Bio Inc. (2023 - 2016)

Year	Inventory	Inventory Growth
2023	- KRW	0.0%
2022	- KRW	0.0%
2021	- KRW	0.0%
2020	- KRW	-100.0%
2019	1.00 KRW	0.0%
2018	- KRW	0.0%
2017	- KRW	0.0%
2016	- KRW	0.0%

Year	Inventory	Inventory Growth
2024 Q1	1.00 KRW	0.0%
2024 Q2	- KRW	-100.0%
2023 Q1	- KRW	0.0%
2023 Q4	- KRW	0.0%
2023 Q3	- KRW	-100.0%
2023 Q2	1.00 KRW	0.0%
2023 FY	- KRW	0.0%
2022 Q1	- KRW	0.0%
2022 Q4	- KRW	100.0%
2022 Q3	-40.35 Billion KRW	0.0%
2022 Q2	- KRW	0.0%
2022 FY	- KRW	0.0%
2021 FY	- KRW	0.0%
2021 Q2	- KRW	0.0%
2021 Q4	- KRW	0.0%
2021 Q3	- KRW	0.0%
2021 Q1	- KRW	0.0%
2020 FY	- KRW	-100.0%
2019 FY	1.00 KRW	0.0%
2018 FY	- KRW	0.0%
2017 FY	- KRW	0.0%
2016 FY	- KRW	0.0%

Peer Inventory Comparison of ABL Bio Inc.

Name	Inventory	Inventory Difference
Sam Chun Dang Pharm. Co., Ltd	35.26 Billion KRW	100.0%
Hyundai Bioscience Co., Ltd.	2.58 Billion KRW	100.0%
ST Pharm Co.,Ltd.	120.73 Billion KRW	100.0%
Cellid, Co., Ltd.	- KRW	NaN%